WEKO3
アイテム
{"_buckets": {"deposit": "910cb52b-14aa-48cc-992c-6fdab05402fb"}, "_deposit": {"created_by": 1, "id": "48626", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "48626"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00048626", "sets": ["1"]}, "author_link": ["901551", "901549", "901559", "901550", "901548", "901553", "901554", "901557", "901556", "901555", "901552", "901558"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2017-06", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "6", "bibliographicPageEnd": "e0178472-13", "bibliographicPageStart": "e0178472-1", "bibliographicVolumeNumber": "12", "bibliographic_titles": [{"bibliographic_title": "PLOS ONE"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Recently, 211At has received increasing attention as a potential radionuclide for cancer radioimmunotherapy. It is a α-particle emitter, which is extremely effective against malignant cells. We demonstrate a method to verify the efficiency of 211At-labeled trastuzumab antibodies (211At-trastuzumab) against HER2 antigens, which has not been determined for radioimmunotherapy. A CR-39 plastic nuclear detector is used for measuring the position and the linear energy transfer (LET) of individual 211At α- particle tracks. The tracks and 211At-trastuzumab-binding cells were co-visualized by using the geometric information recorded on the CR-39. HER2-positive human gastric cancer cells (NCI-N87), labelled with 211At-trastuzumab, were dropped on the centre of the CR-39 plate. Microscope images of the cells and the corresponding α-tracks acquired by position matching were obtained. In addition, 3.5 cm × 3.5 cm macroscopic images of the whole plate were acquired. The distribution of number of α-particles emitted from single cells suggests that 80% of the 211At-trastuzumab-binding cells emitted α-particles. It also indicates that the α-particles may strike the cells several times along their path. The track-averaged LET of the α-particles is evaluated to be 131 keV/μm. These results will enable quantitative evaluation of delivered doses to target cells, and will be useful for the in vitro assessment of 211At-based radioimmunotherapeutic agents.", "subitem_description_type": "Abstract"}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1371/journal.pone.0178472", "subitem_relation_type_select": "DOI"}}]}, "item_8_relation_17": {"attribute_name": "関連サイト", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0178472", "subitem_relation_type_select": "URI"}}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kodaira, Satoshi"}], "nameIdentifiers": [{"nameIdentifier": "901548", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Li, Huizi"}], "nameIdentifiers": [{"nameIdentifier": "901549", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Konishi, Teruaki"}], "nameIdentifiers": [{"nameIdentifier": "901550", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "KItamura, Hisashi"}], "nameIdentifiers": [{"nameIdentifier": "901551", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kurano, Mieko"}], "nameIdentifiers": [{"nameIdentifier": "901552", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hasegawa, Sumitaka"}], "nameIdentifiers": [{"nameIdentifier": "901553", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kodaira, Satoshi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "901554", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Li, Huizi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "901555", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Konishi, Teruaki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "901556", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kitamura, Hisashi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "901557", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kurano, Mieko", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "901558", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hasegawa, Sumitaka", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "901559", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Validating α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Validating α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/48626", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-06-30"}, "publish_date": "2017-06-30", "publish_status": "0", "recid": "48626", "relation": {}, "relation_version_is_last": true, "title": ["Validating α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors"], "weko_shared_id": -1}
Validating α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors
https://repo.qst.go.jp/records/48626
https://repo.qst.go.jp/records/4862692a0e2b2-e23a-4932-92c3-c32509d06d46
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-06-30 | |||||
タイトル | ||||||
タイトル | Validating α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Kodaira, Satoshi
× Kodaira, Satoshi× Li, Huizi× Konishi, Teruaki× KItamura, Hisashi× Kurano, Mieko× Hasegawa, Sumitaka× Kodaira, Satoshi× Li, Huizi× Konishi, Teruaki× Kitamura, Hisashi× Kurano, Mieko× Hasegawa, Sumitaka |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Recently, 211At has received increasing attention as a potential radionuclide for cancer radioimmunotherapy. It is a α-particle emitter, which is extremely effective against malignant cells. We demonstrate a method to verify the efficiency of 211At-labeled trastuzumab antibodies (211At-trastuzumab) against HER2 antigens, which has not been determined for radioimmunotherapy. A CR-39 plastic nuclear detector is used for measuring the position and the linear energy transfer (LET) of individual 211At α- particle tracks. The tracks and 211At-trastuzumab-binding cells were co-visualized by using the geometric information recorded on the CR-39. HER2-positive human gastric cancer cells (NCI-N87), labelled with 211At-trastuzumab, were dropped on the centre of the CR-39 plate. Microscope images of the cells and the corresponding α-tracks acquired by position matching were obtained. In addition, 3.5 cm × 3.5 cm macroscopic images of the whole plate were acquired. The distribution of number of α-particles emitted from single cells suggests that 80% of the 211At-trastuzumab-binding cells emitted α-particles. It also indicates that the α-particles may strike the cells several times along their path. The track-averaged LET of the α-particles is evaluated to be 131 keV/μm. These results will enable quantitative evaluation of delivered doses to target cells, and will be useful for the in vitro assessment of 211At-based radioimmunotherapeutic agents. | |||||
書誌情報 |
PLOS ONE 巻 12, 号 6, p. e0178472-1-e0178472-13, 発行日 2017-06 |
|||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1371/journal.pone.0178472 | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0178472 |